Psychedelic Stocks - Shroom stocks - Psilocybin stocks - MDMA stocks

[ProfitScout]

$MINE News: Minerco (MINE) Developer of SHRUCOIN Announces that Davido Joins Rapper Bobby Shmurda and Rowdy Rebel to Appear at June 18th Live Streamed Global Concert Projected to have One Million Tickets Sold Worldwide

Davido, Featured "Coming To America 2", Is The Top Artist From Africa And Has Won Over 20 Music Industry Awards; All Sales Will Be Utilizing Company's SHRUCOIN, An m-PESA's Phone Based Mobile Money Transfer Service.

ANN ARBOR, MI / ACCESSWIRE / May 17, 2021 / Minerco, Inc. "The Magic Mushroom Company" (OTC PINK:MINE) today announced that the largest musical artist in Africa, Davido, will be joining American rappers and songwriters, Bobby Shmurda & Rowdy Rebel to appear in a June 18th global live streaming concert. Ticket sales are projected to reach 1 Million worldwide. Tickets will go on sale Monday via the Company's SHRUCOIN, an m-PESA's Phone Based Mobile Money Transfer Service.

The concert will be released as part of a docudrama to a combined global viewership of over 100 million subscribers through Amazon, Roku and Apple TV as well as its own channel, SHRUTV.com. The concert itself will be available exclusively to concertgoers who have purchased a ticket for $20 in SHURCOINS at www.shrucoin.com, which is owned and operated by Minerco, Inc. According to initial estimates, the Company believes a minimum of one million tickets will be sold primarily in North America, the Caribbean and Africa to this historic event, which is expected to result in record financial contributions to Minerco's bottom-line both for the second fiscal quarter and current fiscal year ended December 31, 2021.

Davido has won over 20 music industry awards and nominated for more, including his most recent ones from AFRIMA for Artist of the Year, Best Male West Africa and Crossing Boundaries with Music Award in 2019. All Africa Music Awards (also referred to as AFRIMA) is an annual awards event. The awards event was established by the International Committee AFRIMA, in collaboration with the African Union (AU) to reward and celebrate musical works, talents and creativity around the African continent while promoting the African cultural heritage.

He has also been nominated &/or awards for: Soul Train Award, The Future Africa Awards, The Kora Awards, The BET Awards, The Ben TV Awards, The Dynamix All youth Awards, The MOBO Awards, The MTV Europe Music Awards, African Muzik Magazine Awards, MTV Africa Music Awards, The World Music Awards, The Channel O Music Awards, The Nigeria Music Video Awards, The 4Syte TV Music Video Awards, The Ghana Music Awards, The City People Entertainment Awards, The Headies, The Nigerian Entertainment Awards, and The Nickelodeon Kids' Choice Awards.

Julius Jenge, Chief Executive Officer of Minerco, Inc. said: "We are excited that our new crypto based payment system, is to be employed for first time in music industry via this global live streaming concert, with some of the most important artists in the world. We believe that our technology and SHRUCOIN will revitalize the music industry and level the playing field for artists to receive their full share of revenue and appreciation, now and in the future. Plus our payment system also useful for innovative legal recreational and medical marijuana and psychedelics sales via Visa and Mastercard cards."

To be added to the Company's investor email lists, please email [e-mail].

About Minerco, Inc.

Minerco, Inc., "The Magic Mushroom Company" (OTC Pink: MINE), is the pioneering company specializing in the research, production, and distribution of psilocybin mushroom products ("Magic Mushrooms"). The Blockchain token SHRU can be used for purchases relating to psilocybin and cannabis. SHRU can be purchased at www.shrucoin.com. Consumers can also utilize the SHRUCOIN Pay app by visiting www.shrucoinpay.com. To learn more about Minerco, Inc. please visit www.minercoinc.com.

Follow us on twitter
@minercoinc

Investor relations
[e-mail]

MINERCO, INC. FORWARD-LOOKING STATEMENTS

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts, including, without limitation, statements regarding the investment offerings and the terms thereof, are forward-looking statements. When used in this press release, words such as we "expect," "intend," "plan," "estimate," "anticipate," "believe," "should," or the negative thereof or similar terminology are generally intended to identify forward-looking statements. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Investors should not place undue reliance upon forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Minerco Investor Relations

Phone: [phone]

SOURCE: Minerco, Inc.



View source version on accesswire.com:
https://www.accesswire.com/647709/Minerco-MINE-Developer-of-SHRUCOIN-Announces-that-Davido-Joins-Rapper-Bobby-Shmurda-and-Rowdy-Rebel-to-Appear-at-June-18th-Live-Streamed-Global-Concert-Projected-to-have-One-Million-Tickets-Sold-Worldwide

[0001-stocks]

anyone look at $MINE, a publicly traded psychedelic company

[ListenToMe]

PSYCF is Definitely my fav! The team is Stacked!

https://investorshub.advfn.com/Psyched-Wellness-Ltd-PSYCF-29774/

[ProfitScout]

$PSYC News: February User Metrics for PSYC’s Psychedelic Spotlight Platform Reflect Impressive Growth Rate of 40%

Growth of Psychedelic Spotlight Creates Potential Revenue Opportunities for PSYC

LAS VEGAS, NV, March 04, 2021 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) the first publicly traded digital media company within the emerging sector of medicinal psychedelics, is pleased to announce that following consecutive months of sustained exponential growth of its Psychedelic Spotlight website, the Company will expand its focus on integrating advertisement and media partnership opportunities and with the intent of infusing the Company with its first steady revenue stream since it’s pivot into the emerging medicinal psychedelic sector.

Metrics and analytics taken from the Company’s Psychedelic Spotlight website for the month of February demonstrated continued growth for the site in users, sessions, and average time of session. The month of February alone also represented the site’s largest single growth spike since it’s official launch in June 2020 with metrics for users and sessions each growing by over 40% respectively from the previous month.

“In the last few months we have seen our Psychedelic Spotlight platform continue to grow quite significantly,” said Global Trac Solutions, Inc. CEO, David Flores. “I believe this is a result of not just an increase in general interest surrounding the medicinal psychedelic industry but is more so a result of the reputation we are establishing for ourselves as an industry-leading reputable source for all things related to psychedelics.”

In addition to the Psychedelic Spotlight website, the Company also features two weekly newsletters: The Psychedelic Spotlight Newsletter and the PSYC Stock Report, along with podcast channels featuring exclusive interviews and available on platforms such as YouTube, Apple and Spotify.

“Now that we have established a strong and reputable identity for Psychedelic Spotlight, I believe the time is now for us to begin leveraging its position within this burgeoning industry as a tool for driving revenue,” said Flores. “The metrics we are seeing the site produce are, in my opinion, an indicator that we have elevated it to the point where we can reasonably demonstrate its value and potential in helping specific brands and companies more effectively target and grow their audience through advertisement placements across our growing number of platforms. I intend for this to become a primary focus of ours heading into the next several months and with the expectation of having revenue reflected in our financials in the earliest time frame possible. It is also my intent to continue maintaining an aggressive, yet strategic, approach with identifying other potential revenue generating opportunities that may contribute to additional value for PSYC in the years to come.”

About Global Trac Solutions, Inc. (OTCPink: PSYC)

At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.

PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.

We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.

Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.

Corporate Contact:

Global Trac Solutions, Inc. (PSYC)
http://www.globaltracsolutions.com
[phone]
[e-mail]
OTCPINK: PSYC

[green*13]

https://www.horizonsetfs.com/PSYK#

[green*13]

CMPS.MMEDF.CLXPF.MYCOF.CGC https://realmoney.thestreet.com/investing/cannabis/as-the-focus-on-psychedelic-stocks-increases-so-do-the-valuations-15535386?puc=yahoo&cm_ven=YAHOO

[green*13]

https://talkmarkets.com/content/stocks--equities/new-psychedelics-etf-is-another-sector-milestone?post=291805

[green*13]

32 psychedelic stocks.

[ProfitScout]

$PSYC Executes MOU With Digital Mental Health Startup, PsycheDev Inc.

PSYC Aims to Co-Develop Digital Mental Health Platform Through JV Partnership

LAS VEGAS, NV, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a digital media leader within the emerging sector of medicinal psychedelics, is pleased to announce that the Company has entered into a Memorandum of Understanding (“MOU”) with PsycheDev Inc. (“PsycheDev”), a Canadian based start-up company focused on the development and deployment of technology-driven mental wellness-enhancing solutions.

In effect, the execution of the MOU outlines the general terms to be applied by each of the respective companies in entering into advanced discussions surrounding the intended establishment of a Joint Venture Partnership Agreement (the “JV”) which will focus on the effective co-development and launch of the PsycheDev platform and app. Furthermore, it is the intent of PSYC, via the anticipated execution of a JV, to acquire an equity stake in PsycheDev through a capital investment and to work alongside the company’s Founder and CEO, Justin Roy, to bring their cutting-edge digital mental health platform to market during the latter quarters of 2021. No assurances can be provided that the JV will be consummated or that the underlying business will be profitable.

“We are extremely pleased to advance our discussions with PsycheDev through the execution of this MOU,” said Global Trac Solutions, Inc. CEO, David Flores. “Our collective focus over the next several days will be to meticulously work through the process of finalizing a JV Partnership Agreement with them so that we can formally begin collaboration efforts. In my opinion, this represents a unique, exciting, and value-driven opportunity for PSYC to collaborate on the development of this highly intriguing early-stage concept and position ourselves to enter the burgeoning sector of digital mental health.”

“We are very glad to collaborate with a team that has the same vision for mental health’s future,” said PsycheDev Inc. Founder and CEO, Justin Roy. “We must join forces to work on building a healthier society and this partnership will bring us one step closer by helping us make the serious, therapeutic use of plant medicine much more accessible. This means a lot, as Global Trac Solutions will go a long way in helping us bring better quality solutions to people much faster.”

“We are currently in the midst of an evolution of digital tools that are transforming society’s approach to mental health and wellbeing,” said Flores. “I truly believe that by combining Mr. Roy’s vision for PsycheDev with the business development and go-to-market experience and knowledge the PSYC team has to offer, we have the potential of bringing a truly unique and highly-beneficial digital resource to the masses.”

About Global Trac Solutions, Inc. (OTCPink: PSYC)

At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.

PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.

We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.

Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.

Corporate Contact:

Global Trac Solutions, Inc. (PSYC)
www.globaltracsolutions.com
[phone]
[e-mail]
OTCPINK: PSYC

[ProfitScout]

$PSYC: Leading Psychedelic Media Site Launches New Digital Platform

PsychedelicSpotlight.com upgrades website for user experience and increased content

Las Vegas, Nevada, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that the Company has launched a new web platform for its Psychedelic Spotlight web magazine.

The new site is part of the continued growth Psychedelic Spotlight is experiencing. In Q4 of 2020 a record number of new users visited the site, breaking page view records.

“When PSYC initially launched Psychedelic Spotlight last spring I’m not sure if anyone could fathom how quickly it would grow into one of the most prominent sources for news, information, and resources within the sector of medicinal psychedelics,” said David Flores, Global Trac Solutions, Inc. CEO. “The new site will present a sleeker and more appealing visual experience for our audience. However, some of the most important and beneficial updates and changes we have infused the site with are on the backend. This new site has been developed with SEO and Google ranking analytics in mind in order to more effectively position it to capture as much of the growing audience within this sector as possible.”

“I’m thrilled to bring this new platform to our readers,” said Jill Ettinger, Psychedelic Spotlight’s Director of Content. “They keep telling us how much they love the content at Psychedelic Spotlight, and now we have a platform that’s only going to add to that positive experience as well as sustain its continued growth and expansion in the months ahead.”

The Company, through its digital media marketing partner, SunCity Advising, expects to rollout additional pages and features for the Psychedelic Spotlight website over the next several weeks in its ongoing mission of delivering the most resourceful and content-rich web platform in the sector of medicinal psychedelics.

About Global Trac Solutions, Inc. (OTCPink: PSYC)

At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.

PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.

We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.

Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.

Corporate Contact:

Global Trac Solutions, Inc. (PSYC)
http://www.globaltracsolutions.com
[phone]
[e-mail]
OTCPINK: PSYC

[gym gravity]

Psychedelic healing...anyone see the Lisa Ling show? I dvred because i'm out of town but xfinity wont let me watch it away from my own wifi.

[ProfitScout]

$PSYC News: Following Appearance on HBO’s Real Sports, Retired UFC Fighter, Ian McCall, Joins PSYC CEO on Psychedelic Spotlight Podcast

Psychedelic Spotlight Demonstrates Continued Emergence as Digital Media Leader Within Psychedelic Industry Through Exclusive New Content

LAS VEGAS, NV, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a digital media leader within the emerging sector of medicinal psychedelics, is pleased to announce that its episode of the Psychedelic Spotlight podcast released today via its newsletter and streaming on Spotify and Apple, features an exclusive interview with retired MMA and UFC fighter, Ian McCall, on the heels of his appearance on HBO’s Real Sports with Bryant Gumble.

In the podcast, PSYC CEO, David Flores, speaks with McCall about his path to recovery from PTSD and his addiction to painkillers through his mindful integration of psychedelics along with a more holistic approach to his daily life. The episode also chronicles the stories of other retired professional athletes who, similar to McCall, have discovered healing and long sought-after peace of mind through the use of psychedelics following their careers participating in high-impact sports that subjected them to brain injuries and trauma.

“Ian’s story is an inspiration,” said Global Trac Solutions, Inc. CEO, David Flores. “I applaud HBO for devoting a segment of Real Sports to the healing powers of psychedelics, and for shedding an important light on the very serious trauma and mental health conditions that far too many retired professional sports athletes suffer from. I really believe that this feature on HBO is yet another example of the emergence of psychedelics within mainstream society. Features like this are a very solid demonstration of why I remain encouraged over the legitimate path I believe psychedelics have to become a full-fledged industry and a viable treatment option for some of society’s most prevalent mental health conditions.”

The Company contends that the Real Sports episode is just one in a growing number of features released over the last several months by some of the more prominent news networks in the US, including special segments from CBS’ 60 Minutes and CNN’s “This Is Life” which each highlight the encouraging healing potential associated with psychedelics.

“We here at PSYC remain determined to expand the conversations around psychedelics and help normalize the tremendous power these substances hold,” Flores said. “There’s never been a more critical time to have these conversations and we applaud Ian for speaking out about his experience and for the fantastic healing resources he is offering through the work he is involved in with The McCall Method.”

The Psychedelic Spotlight podcast can be found here.

About Global Trac Solutions, Inc. (OTCPink: PSYC)

At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.

PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.

We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.

Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.

Corporate Contact:

Global Trac Solutions, Inc. (PSYC)
http://www.globaltracsolutions.com
[phone]
[e-mail]
OTCPINK: PSYC

[MomsSpaghetti]

$MMEDF - MindMed should be looked at before the train leaves the station.

[ProfitScout]

$PSYC: Critical Election Day Victories for Psychedelics Continue the Industry’s Momentum

Key psychedelic drug ballot initiatives pass in Oregon and Washington, D.C. setting a bright future for mental health care in the U.S.

LAS VEGAS, NV, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) applauds the successful passage of two key psychedelic ballot initiatives in Oregon and the nation’s capital following the November 3rd election. These victories continues to highlight a critical and ongoing shift in support of medicinal psychedelics in the U.S.

Oregon’s Measure 109, a Psilocybin Therapy Initiative, will allow for the development of a state-regulated program for psilocybin-assisted therapy aimed at treating those suffering from debilitating mental health conditions such as depression, anxiety, PTSD, and addiction.

In a July 2020 interview with PSYC CEO David Flores, Sheri Eckert, one of the chief petitioners behind Measure 109, explained that “it’s important to create new options.” Eckert said psilocybin assisted therapy can help. “This approach will bring a new tool for mental health and wellness into the field of care, and we need this because our current treatment options are not working for enough people. For some, psilocybin therapy might even eliminate the need for daily dosing of psych meds, and that’s good news, because the goal is to heal, not to prescribe more pills.”

“Congratulations to Tom and Sheri Eckert for the tireless work they have put into Measure 109,” said Flores. “We are honored to have had the opportunity to share the important mission and message associated with Measure 109 through our Psychedelic Spotlight platform.”

Washington D.C.’s Initiative 81 decriminalizes several plant and fungi-based psychedelic substances. And with this passage, DC joins other cities including Denver, Oakland, and Santa Cruz, Calif., and Ann Arbor, Mich., which have already decriminalized plant and fungi-based psychedelics.

“We here at PSYC are quite encouraged with the passage of these ballot initiatives and how they further demonstrate the very viable path for the emergence of medicinal psychedelics as an industry,” Flores said. “We look forward to continuing to serve as a voice and resource for the advancement of medicinal psychedelics, helping to develop and shape what we believe is materializing into one of the most prominent and critical industries of our time.”

About Global Trac Solutions, Inc. (OTCPink: PSYC)

At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.

PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.

We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.

Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.

Corporate Contact:

Global Trac Solutions, Inc. (PSYC)
http://www.globaltracsolutions.com
[phone]
[e-mail]
OTCPINK: PSYC

[MustBeTheTruth]

We Should ALl focus on whats happening in the World. What will "Social Distancing" To to peoples Mental Health.

[MustBeTheTruth]

Here’s How Psychedelic Medicine Could Help End the Opioid Epidemic Once and For All

-The Opioid Crisis Has Plagued North America for Decades, and According to the U.S. HHS, it Kills an Estimated 130+ People Per Day in the United States Alone

-Thanks to Recent Advancements in Psychedelic Medicine, There’s Renewed Hope and Optimism Surrounding the Deadly Epidemic

-ATAI Life Sciences, DemeRx and MindMed Are Waging War Against Opioid Addiction By Utilizing This One Little-Known Psychedelic Substance

The opioid crisis isn’t making as many headlines these days due to the rise of the COVID-19 pandemic, which has paralyzed much of the global economy and captivated the attention of billions worldwide. While the Coronavirus continues to sweep across the globe, a different type of epidemic continues to ravage America’s communities and families. We’re talking about the Opioid Epidemic.

Click here to read article

[MustBeTheTruth]

Champignon Brands to Acquire Health Canada Licensed Psychedelic Clinic Operator AltMed

Read News Here

[ed7777777]

More Than A Trip: Psychedelic Drugs Being Used To Help People Quit Smoking In Just One Dose
https://baltimore.cbslocal.com/2020/02/10/johns-hopkins-research-pyschedelic-drugs-shrooms-treating-addiction-quit-smoking-psilocybin/

[ed7777777]

Houston, Texas--(Newsfile Corp. - March 11, 2020) - There's a global march toward psychedelics for medicinal benefits.

While research has been off limits for decades, that's quickly changing - and fast.

In recent years, the US FDA granted Breakthrough Therapy designation for Compass Pathways' psilocybin treatment for depression. Denver, Oakland, and Santa Cruz just decriminalized the use of magic mushrooms. Chicago city leaders just passed a resolution supporting scientific and medicinal research, with a goal of decriminalization.

All on evidence the drug can improve obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating disorders, depression, anxiety, and even smoking.

Even more impressive, a study in the Journal of Psychopharmacology found that a single mushroom-based treatment can help improve the lives of cancer patients' quality of life for nearly five years. This study builds on a 2016 study that provided treatments to 29 people suffering with life-threatening cancer, and were also diagnosed with depression or anxiety.

In addition, "Theoretically, psilocybin helps "loosen" the deeply-rooted patterns of thinking and behavior behind many of these mental disorders, according to King's College London, as highlighted by CNN. It could 'relax' the parts of our brain that control these behaviors, thus allowing old patterns to change or fade. Patients who have received psilocybin have described coming down from the high with "new insights" and changed perspectives on their difficulties."

Before long, big pharmaceutical companies will jump on the bandwagon.

At the moment, venture capitalists are jumping on the opportunity.

"I view the next five years as an absolutely golden window. There's an opportunity to use relatively small amounts of money to have billions of dollars of impact and to affect millions of lives," says angel investor Tim Ferriss, who has poured money into advancing research on the mushroom market, as quoted by Forbes. "There just aren't that many opportunities that are so dramatically obvious."

In addition, a good chunk of venture capital money has been raised to date from firms such as Field Trip Ventures, Numinus, and Tabula Rasa. Compass Pathways, raised $55 million from Thiel Capital and Galaxy Ventures's Michael Novogratz, as well says Fortune.

Before long, big pharmaceutical companies could soon jump on the opportunity, too.

After all, if psychedelics, like mushrooms continue to prove effective in the treatment of depression, ADHD, anxiety, addiction, and neurological disorders, pharmaceutical companies could jump on the opportunity, as well. Traditional pharmaceutical companies already earn billions to manufacture other drugs for such ailments.

If psychedelics can prove themselves effective, it'll open another billion-dollar opportunity.

One of the top companies to watch is Yield Growth, which has made substantial moves into psilocybin mushrooms.

Just recently, Yield Growth developed Ayurvedic mushroom coffees and Ayurvedic mushroom botanical shots for smoothies. In fact, its Ayurvedic coffees and botanical shots are planned for launch in early summer of 2020 and contain immune-boosting medicinal mushrooms: reishi, chaga, lion's mane and turkey tail.

"These formulations provide powerful brain and immune-boosting benefits thanks to their powerful antioxidant and nutrient-rich formulas," said Penny White, CEO of The Yield Growth Corp. "Along with their powerful health profile, these products are made with fair-trade, organic ingredients."

Chaga mushrooms have been used for centuries in Siberia and Asia as medicine to reduce inflammation, boost immunity and improve overall health. Chaga also has the ability to lower high blood sugar and combat abnormal and mutagenic cell growth.

Turkey Tail also contains a community of powerful antioxidants and other compounds that may help boost your immune system and may even fight certain cancers. Some scientific studies have also shown that Turkey Tail may also improve gut bacteria balance.

Reishi is one of the most popular medicinal mushrooms and is known to be used to assist in weight loss, boost immunity and fight certain cancer cells. What makes it unique though are its calming properties thanks to a compound called triterpene that it contains. This can help to promote healing, sharpen focus, alleviate anxiety, ease depression, and encourage better sleep.

Lion's Mane is also packed with antioxidants and also strengthens the immune system, but it also has other unique benefits that foster mental clarity and brain health. For example, it aids in the production of the bioprotein nerve growth factor (NFG) and myelin, which acts as "insulation" around nerve fibers and helps to fight the onset of neurological diseases such as Alzheimer's and multiple sclerosis.

However, that's just part of Yield Growth's story.

Flourish Mushroom Labs Inc. also announced it acquired technology rights from its parent company The Yield Growth Corp. and filed a U.S. provisional patent for the invention of a method of manufacture for a mushroom extract that may be used in a variety of therapeutic and pharmaceutical formulations.

The patent application covers the invention of a unique mushroom extract which may have unique medicinal properties, as well as a method of manufacturing the extract from mushrooms including Psilocybe mexicana, and formulations and emulsions containing the mushroom extract. The mushroom extract may be in the form of an aqueous solution, or it may be a freeze or spray dried powder.

"Our proprietary extraction technology was initially invented to extract compounds from the root of the cannabis plant to manufacture hemp root oil, which we use in a number of our products, including our Urban Juve skincare line," said Penny White, CEO of The Yield Growth Corp. and Flourish Mushroom Labs. "There is now also great interest in using this technology for medicinal mushrooms and psychedelic mushrooms when and where they are legal."

For more information, visit the company's website at https://yieldgrowth.com.

[ed7777777]

Magic Mushrooms One Step Closer to Treating Depression After Successful Clinical Trials https://themindunleashed.com/2020/01/magic-mushrooms-treating-depression-successful-clinical-trials.html?fbclid=IwAR39Vy5ATZBTWXKqIQJRdOy_dEV9U_rtea657fgZmsfygrWedzv-hkAqyEM

[7Secret7Service7]

PI investments Newsletter article $EHVVF

Ehave inc. https://gem.godaddy.com/p/ec5e401/preview

[7Secret7Service7]

The future of psychedelic-assisted psychotherapy | Rick Doblin

[7Secret7Service7]

Santa Cruz decriminalizes magic mushrooms and other natural psychedelics,making it the third US city to take such a step

https://www.cnn.com/2020/01/30/us/santa-cruz-mushrooms-psychedelics-trnd/index.html?fbclid=IwAR3oRX-pj15_gnCmNo1Hl-QOJfCdV8sAzzzRWEn2q-mI1t-tLJm4dpAhvg8

[7Secret7Service7]

The Netherlands is Europe’s Most Psychedelic-Friendly Country

Studies have shown that psychedelics contain many health effects that may help overcome various mental and psychological conditions. The Netherlands is one of the most psychedelic-friendly environments in Europe. Obtaining mushrooms, salvia, peyote, and other similar psychedelics from coffee shops is a common occurrence throughout the country. But what gave rise to this conducive atmosphere and how can other countries emulate it?

What Makes the Netherlands a Psychedelic-Friendly Country?
The Netherlands became one of the most popular countries for psychedelic use due to its relaxed drug laws. The country believes more in educating people on the implications of substances than overly refraining them with dos and don’ts. The idea is that hiding social vices does not make them disappear but rather makes them worse. While stocking and trading drugs without a license remain criminal offenses, the use of many substances is largely decriminalized in the country. This creates the following advantages:

Psychedelics Therapy Centers in the Netherlands
The Netherlands is one of the best places to participate in psychedelic therapies and there are many legal organizations committed to this treatment method. For instance, The Psychedelic Society has taken it upon itself to improve people’s understanding of access to psychedelics. The organization is the pioneer of the psilocybin retreat program in Europe and also helps people identify safe and legal environments for psychedelic therapy with experienced facilitators.

Every year, people from different parts of the world travel to the Netherlands to participate in spiritual and healing retreats. These psychedelic retreats have been an excellent way of overcoming psychological and emotional stress caused by traumatic past experiences.

Many past attendees have also attested to the fact that the experience gave them a better understanding of themselves and helped theme resolve past issues, equipping them with a better sense of judgment and ability to handle hardships. Usually, the program takes a few days or a week and is carefully organized to ensure people’s expectations are met. During this period, attendees do undergo sessions of various activities that propel them into redefining themselves.

Psychedelic Microdosing
If you are still undecided about whether psychedelic treatment is for you, microdosing is a viable option. Psychedelic microdosing means taking very low, sub-perceptual doses of the substances. Sub-perceptual or sub-hallucinogenic refers to making the effects of a drug subtle while still retaining a considerable level of influence on the user.

Microdosing is an old practice that dates back to the 16th century when people took low doses of psilocybin for different health purposes. Studies have shown that psychedelic microdosing has many benefits. Starting with a low dosage of the substance will enable you to evaluate its health benefits and decide if you want to continue, abstain, or increase the dose. In the Netherlands, people use microdosing to test psychedelic effects on certain mental health disorders.

Are Psychedelics Legal in the Netherlands?
Dutch drug policy is driven by the idea that each person should make the final decisions on matters of their own health. However, this does not mean psychedelics are completely legal in the country. Just like many other nations, the Dutch government classifies some drugs, including certain psychedelics, as illegal substances. Essentially, the government divided drugs into two categories: hard drugs and soft drugs.

While hard drugs are forbidden in the Netherlands, soft drugs are mostly legal, but under the condition of “personal use.” Personal use means there is a limit to the quantity that one can have in his or her possession. Substances classified as hard drugs include morphine, LSD, cocaine, and heroin. Soft drugs include all forms of cannabis and psychedelic or psilocybin truffles.

Why Are Truffles Legal and Mushrooms Aren’t?
Psilocybin mushrooms and psilocybin truffles are similar in nature and have the same active compounds, which are psilocin, baeocystin, and psilocybin. The difference, however, is how they are produced. While mushrooms grow out fully, truffles usually grow underground, forming root-like structures.

Before 2008, psychedelic mushrooms and truffles were legal and could be freely bought in the Netherlands. However, in 2008, following the suicide case of a 17-year-old girl who jumped from a building after eating psilocybin mushrooms, the Dutch government banned more than 100 various species of mushrooms. However, sclerotium forms of fungi were excluded from the ban, which makes truffles remain a legal substance in the country.

https://www.psytech.biz/the-netherlands-is-psychedelic-friendly/

[7Secret7Service7]

*VIDEO*Cannabis Industry Experts on the Emerging Psychedelic Medicine Market

VIDEO LINK >

[7Secret7Service7]

Psychedelic Events Are Going Mainstream, Where The Much-Maligned Mushroom Industry Focuses On Mental Health

Forbes article link > https://www.forbes.com/sites/sarabrittanysomerset/2020/01/12/psychadelic-events-are-going-mainstream-where-the-much-maligned-mushroom-industry-focuses-on-mental-health/#5929c7bd402d